Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05453695
PHASE1
Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)
Sponsor: McMaster University
View on ClinicalTrials.gov
Summary
Phase I dose-escalation safety and feasibility of IV DNase I in ICU septic patients.
Official title: Intravenous DNase I for the Treatment of Sepsis: A Phase I Safety and Feasibility Study in ICU Patients
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2023-01-17
Completion Date
2026-09-30
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
DRUG
Intravenous DNase I
Dose-escalating intravenous infusion of DNase I
Locations (1)
Hamilton Health Sciences
Hamilton, Ontario, Canada